WHO ICTRP trial
QuantiFERON-SARS-CoV-2: performance of an Interferon-Gamma Release Assay for…
NL-OMON51150 · Overview of Medical Research in the Netherlands (NL-OMON) · Recruiting
Key facts
| Trial ID | NL-OMON51150 |
|---|---|
| Public title | QuantiFERON-SARS-CoV-2: performance of an Interferon-Gamma Release Assay for COVID-19 before and after vaccination against SARS-CoV-2 |
| Scientific title | QuantiFERON-SARS-CoV-2: performance of an Interferon-Gamma Release Assay for COVID-19 before and after vaccination against SARS-CoV-2 - QFN-SARS: T cell responses pre- and post-vaccination |
| Primary sponsor | Qiagen Sciences |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Recruiting |
| Study type | Observational invasive |
| Countries | The Netherlands |
| Conditions | corona COVID-19;10047438;corona;COVID-19 |
| Interventions | ;COVID-19;QuantiFERON;SARS-CoV-2;T cell response |
| Registration date | Jul 16, 2021 |
| Target size | 950 |
| Secondary IDs | NL77844.028.21 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: